Theralase Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Theralase Technologies generated cash of -$4,072,806, which is more than the previous year. Cash used in financing activities reached the amount of $2,645,364 last year. Net change in cash is therefore -$1,464,706.
Cash Flow
| 2014 | -3.62M | -114.11K | 3.89M |
|---|---|---|---|
| 2015 | -5.04M | -248.49K | 7.71M |
| 2016 | -4.88M | -294.61K | 3.80M |
| 2017 | -4.25M | -410.36K | 1.95M |
| 2018 | -1.21M | -133.53K | 2.12M |
| 2019 | -6.56M | -533.20K | 18.61M |
| 2020 | -4.44M | -164.57K | -57.56K |
| 2021 | -4.03M | -100.82K | -57.36K |
| 2022 | -5.13M | -70.41K | 3.02M |
| 2023 | -4.07M | -37.26K | 2.64M |
TLT.V Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.50M | 3.69M | 7.88M | 12.54M | 1.03M | 253.90K | 2.97M | 4.34M | 1.92M | 1.76M |
Operating activities | ||||||||||
Net income | -4.57M | -5.23M | -4.41M | -5.59M | -7.41M | -3.35M | -6.09M | -4.92M | -5.20M | -2.58M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 286.12K | 313.23K | 276.15K | 272.27K | 255.26K | 222.93K | 253.93K | 149.29K | 134.99K | 82.89K |
Stock-based compensation expense | 621.24K | 191.66K | 318.35K | 912.03K | 394.56K | 0 | 494.19K | 491.48K | 508.27K | 206.89K |
| Deferred income tax benefit | 621.24K | 191.66K | 318.35K | 912.03K | 394.56K | 0 | 494.19K | 491.48K | 508.27K | 206.89K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -25.28K | -31.18K | 229.18K | 389.35K | -38.38K | 254.45K | 20.23K | 9.55K | -557.63K | -323.92K |
Inventories | -172.65K | 80.65K | -113.94K | 270.32K | 141.70K | 182.19K | 169.29K | -305.99K | -617.89K | -105.22K |
Accounts payable | 389.76K | -265.60K | -264.78K | -755.62K | 56.58K | 1.27M | 727.4K | -306.55K | 692.51K | -889.32K |
Cash generated by operating activities | -4.07M | -5.13M | -4.03M | -4.44M | -6.56M | -1.21M | -4.25M | -4.88M | -5.04M | -3.62M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -37.26K | -70.41K | -100.82K | -164.57K | -533.20K | -133.53K | -410.37K | -296.21K | -248.49K | -114.11K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 1.6K | 0 | 0 |
Cash generated by investing activities | -37.26K | -70.41K | -100.82K | -164.57K | -533.20K | -133.53K | -410.36K | -294.61K | -248.49K | -114.11K |
Financing activities | ||||||||||
Common Stock Issued | 2.76M | 2.72M | -750 | -5.28K | 17.48M | 2.08M | 1.95M | 3.80M | 7.00M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -117.14K | 0 | -56.61K | -52.27K | -60.23K | 0 | 0 | 0 | 0 | -507 |
Cash used in financing activities | 2.64M | 3.02M | -57.36K | -57.56K | 18.61M | 2.12M | 1.95M | 3.80M | 7.71M | 3.89M |
Net Change In Cash | -1.46M | -2.18M | -4.18M | -4.66M | 11.51M | 779.79K | -2.71M | -1.37M | 2.41M | 154.12K |
Cash at end of period | 43.91K | 1.50M | 3.69M | 7.88M | 12.54M | 1.03M | 253.90K | 2.97M | 4.34M | 1.92M |